Chemed Corporation
CHE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $625 | $619 | $647 | $640 |
| % Growth | 1% | -4.4% | 1.1% | – |
| Cost of Goods Sold | $444 | $434 | $431 | $406 |
| Gross Profit | $181 | $185 | $216 | $234 |
| % Margin | 28.9% | 29.8% | 33.5% | 36.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $106 | $99 | $106 | $104 |
| SG&A Expenses | $106 | $99 | $106 | $104 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $17 | $16 | $16 |
| Operating Expenses | $106 | $117 | $122 | $120 |
| Operating Income | $75 | $68 | $95 | $114 |
| % Margin | 12% | 11% | 14.6% | 17.8% |
| Other Income/Exp. Net | $9 | $3 | $1 | $6 |
| Pre-Tax Income | $84 | $71 | $96 | $120 |
| Tax Expense | $19 | $19 | $24 | $30 |
| Net Income | $64 | $52 | $72 | $90 |
| % Margin | 10.3% | 8.5% | 11.1% | 14.1% |
| EPS | 4.46 | 3.6 | 4.91 | 6.08 |
| % Growth | 23.9% | -26.7% | -19.2% | – |
| EPS Diluted | 4.46 | 3.57 | 4.86 | 6.02 |
| Weighted Avg Shares Out | 15 | 15 | 15 | 15 |
| Weighted Avg Shares Out Dil | 15 | 15 | 15 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $3 | $2 | $3 |
| Interest Expense | $2 | $0 | $0 | $0 |
| Depreciation & Amortization | $16 | $16 | $16 | $16 |
| EBITDA | $102 | $88 | $112 | $136 |
| % Margin | 16.3% | 14.2% | 17.3% | 21.3% |